CHEMOMAB THERAPEUTICS LTD., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt SecuritiesIndenture • April 30th, 2021 • Chemomab Therapeutics Ltd. • Pharmaceutical preparations • New York
Indenture, dated as of [·], 20__, among Chemomab Therapeutics Ltd., a company organized under the laws of the State of Israel under company number 51-4694991 and having its registered office at Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002 (the “Company”), and [Trustee], as trustee (the “Trustee”):
Chemomab Therapeutics Ltd. American Depositary Shares Each Representing 20 Ordinary Shares (no par value) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 30th, 2021 • Chemomab Therapeutics Ltd. • Pharmaceutical preparations • New York
Chemomab Therapeutics Ltd. a company organized under the laws of Israel (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“Cantor” or the “Agent”), as follows:
